Jupiter Neurosciences enters new orbit in Parkinson’s race

Jupiter Neurosciences starts enrolling patients in a mid-stage study for JOTROL, an oral candidate targeting Parkinson’s at its roots. Targeting Parkinson’s at its roots sounds straightforward in theory, but in practice, it has defeated scientists for decades. Most treatments available today help patients regain some control over movement, but underneath those symptoms, the disease continues […] The post Jupiter Neurosciences enters new orbit in Parkinson’s race appeared first on Longevity.Technology.